EUVIMEDEUVIMED entdecken
Crossref

New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study

Muhammad Taha iD, Fazal Rahim iD, Shawkat Hayat, Sridevi Chigurupati iD, Khalid Mohammed Khan iD, Syahrul Imran iD, Syed Adnan Ali Shah iD, Nizam Uddin iD, Shatha Ghazi Felemban, Vijayan Venugopal

Future Medicinal Chemistry · 2023-03 · 15 (5) · 405-419

DOI: 10.4155/fmc-2022-0306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, online erschienen am 04.04.2023. Verfasst von Muhammad Taha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute for Research & Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi …. Hauptthemen laut MEDLINE: Heterocyclic Compounds, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heterocyclic CompoundsDiabetes MellitusAnimalsMiceMolecular Docking Simulationalpha-GlucosidasesKineticsGlycoside Hydrolase InhibitorsStructure-Activity Relationshipalpha-AmylasesMolecular Structure

Stichwörter der Autor:innen

diabetics II inhibitorsenzymatic kinetics studynew pyrrolopyridine-based thiazolotriazole

Substanzen

alpha-GlucosidasesGlycoside Hydrolase InhibitorsHeterocyclic Compoundsalpha-Amylases

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Institute for Research & Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi Arabia.
  • Department of Chemistry, Hazara University, Mansehra, Khyber Pakhtunkhwa, 21300, Pakistan.
  • Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, 52571, Kingdom of Saudi Arabia.
  • University Center for Research & Development (UCRD), Chandigarh University,Gharuan, Punjab, 140413, India.
  • H. E. J. Research Institute of Chemistry, International Center for Chemical & Biological Sciences, University of Karachi, Karachi, Pakistan.
  • Atta-ur-Rahman Institute for Natural Product Discovery (AuRIns), Universiti Teknologi MARA Cawangan Selangor Kampus Puncak Alam, Bandar Puncak Alam, Selangor D. E., 42300, Malaysia.

ORCID-Profile: Muhammad Taha, Fazal Rahim, Sridevi Chigurupati, Khalid Mohammed Khan, Syahrul Imran, Syed Adnan Ali Shah, Nizam Uddin

Zitieren

APA

Taha, M., Rahim, F., Hayat, S., Chigurupati, S., Khan, K. M., Imran, S., Ali Shah, S. A., Uddin, N., Felemban, S. G., & Venugopal, V. (2023). New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study. Future Medicinal Chemistry, 15(5), 405-419. https://doi.org/10.4155/fmc-2022-0306

Vancouver

Taha M, Rahim F, Hayat S, Chigurupati S, Khan KM, Imran S, et al. New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study. Future Medicinal Chemistry. 2023;15(5):405-419. doi:10.4155/fmc-2022-0306

BibTeX
@article{Taha2023,
  author = {Taha, Muhammad and Rahim, Fazal and Hayat, Shawkat and Chigurupati, Sridevi and Khan, Khalid Mohammed and Imran, Syahrul and Ali Shah, Syed Adnan and Uddin, Nizam and Felemban, Shatha Ghazi and Venugopal, Vijayan},
  title = {New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study},
  journal = {Future Medicinal Chemistry},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {405--419},
  doi = {10.4155/fmc-2022-0306}
}
Kostenlos starten →